Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 September 2020 | Story Eugene Seegers | Photo Sonia du Toit (Kaleidoscope Studio)
Dr Marinkie Madiope in official UFS gown
Dr Maria Madiope

Everywhere you look, our colleagues at the UFS are stepping up and stepping into the new digital space. With the move to virtual events, staff members at the university are able to participate in discussions and webinars across the continent at various other institutions of higher learning. 

One such virtual event recently took place for Women’s Month. The Tshwane University of Technology hosted the Annual Adelaide Tambo Memorial Lecture on 27 August. The theme was Is the face of the boardroom in global organisations changing women representation in influential positions?

Dr Phumzile Mlambo-Ngcuka, United Nations Under-Secretary General and Executive Director of UN Women, focused in her presentation on themes regarding girls’ education and women’s health, both of which have been threatened by the COVID-19 pandemic.

As the respondent, Dr Maria Madiope, Principal of the UFS South Campus, dealt with the patriarchal domination and violence that modern women and girls endure, as well as the way “their sexuality and aptitude is disrespected and how they are subjugated and side-lined in the political, corporate, social, and cultural arena.” She said that it is incumbent on the modern generation of women to reignite the flame that fuelled the struggle for feminine recognition and equality. “We are beholden not only to the legacy of those that came before us, but also to the eager eyes that look up to us,” she concluded. 

Dr Madiope also announced her support for Dr Mlambo-Ngcuka’s Generation Equality campaign against gender-based violence, and she echoed the sentiments of the rallying hashtag #JustChair, which breaks down discrimination based on the use of gendered terms such as ‘chairman’ for the leader of a meeting or corporation.

Dr Adelaide Tambo’s life was characterised by a love of knowledge, as she believed that people need as much power to be able to handle challenges facing the country, the continent, and the planet. She strove for the emancipation of women in general, focusing on the importance of education and how it can improve a woman’s life, and encouraged a strong culture of learning.

The event was livestreamed on Facebook and Zoom; go to https://www.facebook.com/805899996152814/videos/1036964343420927 to watch the full presentation.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept